Sarah Josefsson

Image of Sarah Josefsson
Norwegian version of this page
Visiting address Ullernchausseen 70 None 0372 OSLO
Postal address Postboks 4950 Nydalen 0424 OSLO
Other affiliations Faculty of Medicine (Student)


  • Josefsson, Sarah Elisabet; Beiske, Klaus; Blaker, Yngvild Nuvin; Førsund, Mette S; Holte, Harald; Østenstad, Bjørn; Kimby, Eva; Köksal, Hakan; Wälchli, Sébastien; Bai, Baoyan; Smeland, Erlend B; Levy, Ronald; Kolstad, Arne; Huse, Kanutte & Myklebust, June (2019). TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma. Cancer immunology research.  ISSN 2326-6066.  7(3), s 355- 362 . doi: 10.1158/2326-6066.CIR-18-0351 Full text in Research Archive.
  • Köksal, Hakan; Dillard, Pierre; Josefsson, Sarah Elisabet; Maggadottir, Solrun Melkorka; Pollmann, Sylvie Mireille; Fåne, Anne; Blaker, Yngvild Nuvin; Beiske, Klaus; Huse, Kanutte; Kolstad, Arne; Holte, Harald; Kvalheim, Gunnar; Smeland, Erlend B; Myklebust, June Helen; Inderberg, Else Marit & Wälchli, Sébastien (2019). Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma. Blood Advances.  ISSN 2473-9529.  3(8), s 1230- 1243 . doi: 10.1182/bloodadvances.2018029678 Full text in Research Archive.
  • Josefsson, Sarah Elisabet Göthberg; Huse, Kanutte; Kolstad, Arne; Beiske, Klaus; Pende, Daniela; Steen, Chloe Beate; Inderberg, Else Marit; Lingjærde, Ole Christian; Østenstad, Bjørn; Smeland, Erlend B; Levy, Ronald; Irish, Jonathan M. & Myklebust, June (2017). T cells expressing checkpoint receptor TIGIT are enriched in follicular lymphoma tumors and characterized by reversible suppression of T-cell receptor signaling. Clinical Cancer Research.  ISSN 1078-0432.  24(4), s 870- 881 . doi: 10.1158/1078-0432.CCR-17-2337 Full text in Research Archive.

View all works in Cristin

Published Feb. 13, 2019 12:36 PM - Last modified Feb. 20, 2019 11:08 AM